PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
|Articles|October 2, 2021
- Pharmaceutical Technology, October 2021 Issue
- Volume 45
- Issue 10
Small Bore Tubing Connectors
Colder Products Company MicroCNX Series Connectors provide an alternative to tube welding for small-volume, closed aseptic processes.
MicroCNX connectors are specifically designed for small-volume processes involving 1/16 in. (1.6 mm), 3/32 in. (2.4 mm), and 1/8 in. (3.2 mm) small-bore tubing. The connectors can be incorporated into pre-made tubing assemblies.
To use the aseptic connector, users must pinch to remove the protective cover, click together the connector halves, and pull out the protective membranes to allow flow to begin. This process is intended to be a simpler solution to traditional tube welding, which requires maneuvering the tube welder into position, equipment maintenance, and precise technique.
Articles in this issue
almost 5 years ago
Automating Aseptic Manufacturingalmost 5 years ago
Considering Bio/Pharma Reformulation Strategiesalmost 5 years ago
Pharma Sets a Foundation for Greener API Manufacturingalmost 5 years ago
Adopting Continuous Manufacturing for Solid-Dose Drug Productsalmost 5 years ago
Determining Shelf Life: Reading the Stability Testing Dataalmost 5 years ago
Trends Affecting Biopharmaceutical Manufacturingalmost 5 years ago
European Pharmacopoeia Updates: EDQM Tackles Nitrosamine Impuritiesalmost 5 years ago
Public Trust in Medicine Quality as Public Health Challenges Emergealmost 5 years ago
FDA Moves to Advance Innovative ExcipientsRelated to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.